Seeing Is Believing
AMGN is currently covered by 19 analysts with an average price target of $351.47. This is a potential upside of $31.25 (-9.33%) from yesterday's end of day stock price of $387.64.
Amgen's activity chart (see below) currently has 581 price targets and 446 ratings on display. The stock rating distribution of AMGN is 35.56% BUY, 62.22% HOLD and 2.22% SELL.
Analysts average stock forecasts to be materialized ratio is 90.4% with an average time for these price targets to be met of 547.39 days.
Highest price target for AMGN is $427, Lowest price target is $272, average price target is $351.47.
Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 13-Jul-2026.
Amgen is a biotechnology company that specializes in developing, manufacturing, and delivering human therapeutics.
The company’s research focuses on six main therapeutic areas, which include inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.
Amgen produces drugs such as Enbrel, Neulasta, Prolia, Xgeva, Aranesp, KYPROLIS, and Repatha, which treat anemia, cardiovascular disease, multiple myeloma, osteoporosis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis.
Amgen was founded in 1980 and is headquartered in Thousand Oaks, California.
Currently out of the existing stock ratings of AMGN, 16 are a BUY (35.56%), 28 are a HOLD (62.22%), 1 are a SELL (2.22%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 20-May-2025
$343
$-33.04 (-8.79%)
$340
17 days ago
(13-Jul-2026)
4/5 (80%)
$-17.45 (-4.84%)
30
Buy Since 26-Jan-2026
$420
$43.96 (11.69%)
$400
17 days ago
(13-Jul-2026)
31/34 (91.18%)
$59.55 (16.52%)
798
Hold Since 10-Feb-2022
$333
$-43.04 (-11.45%)
$340
22 days ago
(08-Jul-2026)
22/25 (88%)
$-34.99 (-9.51%)
622
Hold Since 24-Nov-2025
$340
$-36.04 (-9.58%)
$327
23 days ago
(07-Jul-2026)
20/22 (90.91%)
$-28.1 (-7.63%)
253
Hold Since 07-Oct-2024
$350
$-26.04 (-6.92%)
$350
24 days ago
(06-Jul-2026)
29/33 (87.88%)
$-16.44 (-4.49%)
252
What is AMGN (Amgen) average time for price targets to be met?
Which analyst has the current highest performing score on AMGN (Amgen) with a proven track record?
Which analyst has the most public recommendations on AMGN (Amgen)?
Which analyst is the currently most bullish on AMGN (Amgen)?
Which analyst is the currently most reserved on AMGN (Amgen)?